Hypoallergenic allergen derivatives of Pru p 3 for immunotherapy of IgE-mediated peach allergy
Clinical and Translational Allergy volume 3, Article number: P177 (2013)
IgE-mediated allergy to peach represents a frequent cause of severe anaphylactic reactions in Mediterranean countries. Pru p 3, a nonspecific lipid transfer protein (LTP) from peach, was identified as an important elicitor of IgE-mediated food hypersensitivity reactions to peach. Specific immunotherapy is currently the only allergen-specific and disease-modifying treatment of allergies, but has so far not been applied to food allergic patients due to the high risk of IgE-mediated side effects. Hypoallergenic Pru p 3 derivatives have therefore been constructed in order to minimize side-effects, but these molecules were not immunogenic in animal models.
Two recombinant Pru p 3-derivatives were developed based on the Pru p 3 amino acid sequence, by introduction of point mutations, or rearrangements of Pru p 3 fragments and oligomerization. Genes encoding the resulting Pru p 3 derivatives were cloned into the expression vector pET27b and expressed in Escherichia coli. The proteins were purified by affinity chromatography and analyzed by SDS-PAGE and mass spectrometry. IgE-reactivity was tested by dot blot analysis and immunogenicity was investigated by immunization of rabbits.
Expression of the two recombinant Pru p 3 derivatives in Escherichia coli yielded high amounts of recombinant proteins. They were purified to homogeneity and exhibited a strongly reduced IgE-reactivity when exposed to sera of peach allergic patients. Upon immunization of rabbits the Pru p 3 derivatives induced a robust IgG antibody response specific for natural Pru p 3.
The reported recombinant hypoallergenic Pru p 3 derivatives are candidates for specific immunotherapy of peach allergic patients.
Disclosure of interest
B Linhart: None declared, A Gstoettner: None declared, C Gamez: None declared, I Swoboda: None declared, A Mari: None declared, N Papadopoulos: None declared, R Valenta: Grant/research support from Biomay AG, Vienna, Austria.
This work was supported by a research grant from Biomay AG, Vienna, Austria.
About this article
Cite this article
Linhart, B., Gstoettner, A., Gamez, C. et al. Hypoallergenic allergen derivatives of Pru p 3 for immunotherapy of IgE-mediated peach allergy. Clin Transl Allergy 3 (Suppl 3), P177 (2013). https://doi.org/10.1186/2045-7022-3-S3-P177
- Lipid Transfer Protein
- Specific Immunotherapy
- Vector pET27b
- Food Hypersensitivity
- Expression Vector pET27b